methylprednisolone has been researched along with tetrandrine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, S; Hirano, T; Wang, X; Wu, H; Xu, W; Yamada, H | 1 |
2 other study(ies) available for methylprednisolone and tetrandrine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Methylprednisolone potentiates tetrandrine pharmacodynamics against human T lymphoblastoid leukemia MOLT-4 cells via regulation of NF-κB activation and cell cycle transition.
Topics: Antineoplastic Agents; Benzylisoquinolines; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclins; Drug Synergism; Humans; Methylprednisolone; NF-kappa B; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Signal Transduction | 2020 |